ACIU
AC Immune SA
$2.18
-0.18 (-7.63%)
At close · Jul 16
Market Cap
$220.85M
Shares
101,773,573
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.18
Open$2.35
Day$2.16–2.35
52W$2.00–4.00
Avg vol 30d277K
Short int3.4M · 3.3% float · 13.0d
Short vol74%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−27%
below
Price vs 50-day avg
−15%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
9%
near low
Momentum
relative strength
1-month return
−8%
trailing
6-month return
−40%
trailing
YTD return
−31%
this year
Relative strength
−49%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow
Flat
2 of 47 funds reported for Jun 30 · net 0 sh shares
Insider flow
Distributing
Net -$27.9K over 90 days · 100% sells
Short interest
Falling
3.32% of float · ▼ -4.0% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
47 holders — near 3-yr high, broad support
Squeeze score
59
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−47%
past year
ATR
6.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−27%
Bearish
Price vs 50-day avg
−15%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
9%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow
Flat
2 of 47 funds reported for Jun 30 · net 0 sh shares
Insider flow
Distributing
Net -$27.9K over 90 days · 100% sells
Short interest
Falling
3.32% of float · ▼ -4.0% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
47 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $2 · 9%
52-wk high $4
vs 200-day avg -27%
vs 50-day avg -15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACIU
this stock
AC Immune SA
|
$220.85M | -30.6% | — | — | 3.3% |
|
ONC
BeOne Medicines Ltd.
|
$458.76B | +4.5% | +22179.2% | 933.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.36B | +7.2% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$71.18B | -11.9% | +20.8% | 16.6 | 3.3% |
|
ARGX
Argenx SE
|
$53.68B | +2.0% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACIU | -16.2% | -8.0% | -39.9% | -8.4% | -30.6% |
| SPY | -0.1% | +0.1% | +9.0% | +0.5% | +10.1% |
| vs SPY | -16.0% | -8.1% | -48.9% | -8.9% | -40.7% |